Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02769338 · ClinicalTrials.gov registry record · NA

Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
2,292
Enrollment target

NCT02769338: Completed NA study, sponsored by VA Office of Research and Development.

NCT02769338 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 2,292 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02769338, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
2,292 participants
Enrollment target

Study Summary

This program will seek to implement a quality improvement program to improve the care of Veterans with TIA or minor stroke at 6 Veteran Health Administration Hospitals. The investigators will evaluate the implementation and effectiveness of the quality improvement program.

Primary Outcome

Teams at the 6 intervention sites will be given both the QI program (to improve care) and eCQM data (to monitor the care they are delivering to their patients). The primary effectiveness outcome is the proportion of Veterans who received all of the guideline-concordant processes of care for which they are eligible referred to as the "Without-Fail" care rate. Determined by analysis of electronic medical record data.

Interventions

  • OTHER Quality Improvement Program

Trial Details

FieldValue
Enrollment Target 2,292 participants
Start Date 2016-06-01
Est. Completion 2020-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02769338 record still lists

NCT02769338 is an interventional study that assigns participants to a tested intervention. Its 2,292 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% higher).

The record links to 0 conditions, and to 1 intervention - of which Quality Improvement Program is the first listed.

NCT02769338 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02769338 about?

NCT02769338 is a clinical study titled "Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms". This program will seek to implement a quality improvement program to improve the care of Veterans with TIA or minor stroke at 6 Veteran Health Administration Hospitals. The investigators will evaluate the implementation and effectiveness of the quality improvement program.

What is the current status of trial NCT02769338?

This trial is currently completed. It is a NA study. The enrollment target is 2,292 participants. The study started on 2016-06-01. Estimated completion is 2020-09-30.

What interventions are being tested in trial NCT02769338?

The interventions under investigation include: Quality Improvement Program (OTHER).

Who is sponsoring clinical trial NCT02769338?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02769338's enrollment target sits among peer trials

2,292 48th of 2000 higher than 1,953 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05530343 · 2,298 participants · NA

    Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

  • NCT04124120 · 2,300 participants · NA

    Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  • NCT05237258 · 2,300 participants · NA

    Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

  • NCT05732623 · 2,300 participants

    Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02769338, the US trial registry maintained by the National Library of Medicine. NCT02769338 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.